GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Shares of GSK PLC GSK dropped 1.59% to £13.92 Tuesday, on what proved to be an all-around poor trading session for the stock ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV ...

ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

The UK government said on Tuesday it has confirmed a strain of the H5N5 bird flu virus in commercial poultry at a premises ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...

Fundsmith Equity fell off Interactive Investor's most-bought list as tech funds begin to drop in popularity among retail ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...